Tissue Repair Ltd (TRP) - Total Liabilities
Based on the latest financial reports, Tissue Repair Ltd (TRP) has total liabilities worth AU$607.50K AUD (≈ $429.85K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how liquid is Tissue Repair Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Tissue Repair Ltd - Total Liabilities Trend (2020–2025)
This chart illustrates how Tissue Repair Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see TRP asset base.
Tissue Repair Ltd Competitors by Total Liabilities
The table below lists competitors of Tissue Repair Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tiphone Mobile Indonesia Tbk
JK:TELE
|
Indonesia | Rp4.84 Trillion |
|
PAVmed Inc
NASDAQ:PAVM
|
USA | $12.28 Million |
|
C29 Metals Ltd
AU:C29
|
Australia | AU$155.16K |
|
Octopus Renewables Infra Trust
LSE:ORIT
|
UK | GBX1.50 Million |
|
Simble Solutions Ltd
AU:SIS
|
Australia | AU$1.22 Million |
|
Juno Minerals Ltd
AU:JNO
|
Australia | AU$1.25 Million |
|
TwentyFour Select Monthly Income Fund Ltd
LSE:SMIF
|
UK | GBX9.95 Million |
|
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
|
USA | $7.60 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Tissue Repair Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Tissue Repair Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 20.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tissue Repair Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tissue Repair Ltd (2020–2025)
The table below shows the annual total liabilities of Tissue Repair Ltd from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$662.53K ≈ $468.79K |
-50.96% |
| 2024-06-30 | AU$1.35 Million ≈ $955.85K |
+171.62% |
| 2023-06-30 | AU$497.35K ≈ $351.90K |
-11.13% |
| 2022-06-30 | AU$559.64K ≈ $395.98K |
+4.41% |
| 2021-06-30 | AU$536.00K ≈ $379.25K |
+62.86% |
| 2020-06-30 | AU$329.11K ≈ $232.87K |
-- |
About Tissue Repair Ltd
Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more